DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
This Quarter Return
+12.56%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$283M
AUM Growth
+$21.1M
(+8.1%)
Cap. Flow
-$392K
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
64.36%
Holding
124
New
11
Increased
16
Reduced
11
Closed
18
Top Buys
| 1 |
Westrock Coffee
WEST
|
$4.89M |
| 2 |
Pfizer
PFE
|
$4.16M |
| 3 |
Immunovant
IMVT
|
$2.71M |
| 4 |
LK
Luckin Coffee Inc. American Depositary Shares
LK
|
$2.44M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$2.4M |
Top Sells
| 1 |
Viking Therapeutics
VKTX
|
$13.9M |
| 2 |
FTAI Aviation
FTAI
|
$11.8M |
| 3 |
Ardelyx
ARDX
|
$4.05M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$2.99M |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$1M |
Sector Composition
| 1 | Healthcare | 30.17% |
| 2 | Materials | 23.48% |
| 3 | Financials | 12.05% |
| 4 | Industrials | 6.91% |
| 5 | Communication Services | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Digimarc
DMRC
$171M
| $2.27M | 0.8% |
+83,557
| New | +$2.27M |
|
27
Sanofi
SNY
$122B
| $2.19M | 0.77% |
45,000
-2,000
| -4% | -$97.2K |
|
28
Cenovus Energy
CVE
$29.7B
| $1.9M | 0.67% |
95,000
| – | – |
|
|
VRNA
29
Verona Pharma
VRNA
$9.18B
| $1.85M | 0.65% |
115,000
+82,328
| +252% | +$1.32M |
|
30
Travere Therapeutics
TVTX
$1.75B
| $1.78M | 0.63% |
230,966
+9,961
| +5% | +$76.8K |
|
31
AllianceBernstein
AB
$4.35B
| $1.7M | 0.6% |
49,000
| – | – |
|
32
Syndax Pharmaceuticals
SNDX
$1.39B
| $1.56M | 0.55% |
+65,475
| New | +$1.56M |
|
33
SPDR S&P Biotech ETF
XBI
$5.29B
| $1.52M | 0.54% |
16,000
+13,000
| +433% | +$1.23M |
|
34
Protagonist Therapeutics
PTGX
$3.62B
| $1.52M | 0.54% |
52,368
| – | – |
|
35
Ryman Hospitality Properties
RHP
$6.29B
| $1.39M | 0.49% |
12,000
| – | – |
|
36
Xeris Biopharma Holdings
XERS
$1.27B
| $1.33M | 0.47% |
600,000
+212,090
| +55% | +$469K |
|
37
Vertex Pharmaceuticals
VRTX
$102B
| $1.25M | 0.44% |
3,000
| – | – |
|
|
SYRS
38
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.25M | 0.44% |
233,000
+153,073
| +192% | +$819K |
|
39
Evolus
EOLS
$477M
| $1.12M | 0.4% |
80,000
+6,934
| +9% | +$97.1K |
|
40
Editas Medicine
EDIT
$225M
| $1.04M | 0.37% |
+140,000
| New | +$1.04M |
|
41
Xenon Pharmaceuticals
XENE
$2.99B
| $1.03M | 0.36% |
23,866
| – | – |
|
42
Mondelez International
MDLZ
$79.3B
| $980K | 0.35% |
14,000
| – | – |
|
|
43
Madrigal Pharmaceuticals
MDGL
$9.7B
| $957K | 0.34% |
3,584
-11,216
| -76% | -$2.99M |
|
44
AbbVie
ABBV
$374B
| $917K | 0.32% |
5,037
| – | – |
|
45
Kimberly-Clark
KMB
$42.5B
| $776K | 0.27% |
6,000
| – | – |
|
46
DuPont de Nemours
DD
$31.6B
| $761K | 0.27% |
9,930
| – | – |
|
47
Microsoft
MSFT
$3.76T
| $673K | 0.24% |
1,600
| – | – |
|
48
Corteva
CTVA
$49.2B
| $667K | 0.24% |
11,563
| – | – |
|
49
Dow Inc
DOW
$17B
| $645K | 0.23% |
11,136
| – | – |
|
50
Canadian Natural Resources
CNQ
$65B
| $641K | 0.23% |
16,800
| – | – |
|